查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美脑植入物市场预测至 2030 年 - 区域分析 - 按治疗、应用和最终用户（医院和专科诊所/神经中心）
市场调查报告书
商品编码
1494298

北美脑植入物市场预测至 2030 年 - 区域分析 - 按治疗、应用和最终用户（医院和专科诊所/神经中心）

North America Brain Implants Market Forecast to 2030 - Regional Analysis - by Treatment, Application, and End User (Hospitals and Specialized Clinics/Neurological Centers)
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 订单完成后即时交付

价格

2022年北美脑植入市场价值为31.3197亿美元，预计到2030年将达到77.6872亿美元；预计2022年至2030年复合年增长率为12.0%。

随着老年人口的增加，神经系统疾病的盛行率激增，推动了北美脑植入市场的发展

随着年龄的增长，老年人可能会出现影响其活动能力的神经系统疾病。阿兹海默症、癫痫、帕金森氏症 (PD) 和肌张力失调是影响老年族群最常见的神经系统疾病。根据美国人口普查局2020年人口统计，老年人口达5,580万，占全国人口的16.8%； 2020年，加拿大近六分之一的人口年龄在65岁及以上。 ，预计到 2030 年将达到 22.5%。

美国和加拿大等国家与老年人口成长相关的运动障碍和精神疾病盛行率很高。根据帕金森基金会的数据，帕金森症状在平均 60 岁的人群中很常见。该组织也指出，帕金森氏症的发生率随着年龄的增长而增加；美国有近100 万人患有帕金森氏症，预计到2030 年这一数字将达到120 万人。的文章，约3200 万人患有帕金森氏症全世界都患有阿兹海默症。根据 BrightFocus 基金会 2022 年 10 月发布的阿兹海默症研究情况说明书，2022 年美国诊断出约 50 万例新阿兹海默症病例。阿兹海默症的发生率随着年龄的增长而增加。约650 万65 岁及以上的美国人患有阿兹海默症，预计到2050 年这一数字将达到1,270 万人。根据世界卫生组织(WHO) 2022 年2 月发布的统计数据，约有5,000 万。人类患有癫痫症，其中是全世界最常见的神经系统疾病之一。

神经系统疾病发生率的不断增加，加上老年人口的不断增长，推动了对大脑植入物治疗和控制疾病的需求。深部脑部刺激（DBS）技术用于治疗癫痫病例，因为患者的身体在癫痫发作期间对药物的治疗反应较低，且与手术相关的成功率降低。北卡罗来纳大学教堂山分校的研究人员声称已经在大脑中产生了新的神经元，可以使用 DBS 来刺激这些神经元。阿兹海默症的 DBS 涉及利用类似心臟起搏器的植入装置和两根连接线，将温和的电脉衝直接传递到大脑的穹窿区域。电刺激可以活化大脑中的记忆电路，并增强其功能。因此，DBS 和迷走神经刺激等神经植入物越来越多地用于治疗帕金森氏症和其他神经系统疾病患者。

北美脑植入市场概况

北美脑植入市场分为美国、加拿大和墨西哥。 2022年，美国在该地区占据最大市场份额，预计在预测期内将继续保持主导地位。帕金森氏症(PD) 等神经系统疾病的盛行率不断上升、人们对神经系统疾病的认识不断增强、积极的研究成果以及开发各种刺激器的投资不断增加，是推动美国脑植入物整体市场成长的主要因素。根据帕金森基金会的数据，2020 年美国有93 万人患有帕金森氏症，预计到2030 年这一数字将增加到120 万人。证明是潜在的治疗选择对于PD。据观察，DBS 装置可有效控制与 PD 相关的震颤。根据美国俄勒冈健康与科学大学 (OSHU) 脑研究所的数据，约 90% 的原发性震颤患者在接受 DBS 治疗后症状适度缓解。

根据2022 年3 月发表的一项题为「2022 年阿兹海默症事实与数据」的研究，到2022 年，约650 万65 岁及以上的美国人被发现患有阿兹海默症，预计到2060 年，这一数字将增至1380 万。 2023 年 3 月，密西根理工大学的研究人员使用神经形态运算来提高用于治疗 PD 的 DBS 系统的功效和能源效率。同样，北卡罗来纳大学教堂山分校的研究人员发现，他们能够在大脑中产生新的神经元，并使用 DBS 刺激它们。这个过程有助于恢復患有阿兹海默症的小鼠模型的认知和非认知功能。

技术进步和新产品推出推动了美国脑植入物市场的成长。 2020 年 1 月，雅培的 Infinity DBS 系统获得美国食品药物管理局 (FDA) 批准用于治疗帕金森氏症。该系统针对大脑的特定区域（苍白球内部），该区域与帕金森氏症的症状相关。 2020 年 9 月，波士顿科学公司宣布在欧洲推出 WaveWriter Alpha SCS 系统产品组合。 2023 年 5 月，雅培公司的脊髓刺激器 (SCS) 装置获得美国 FDA 批准，用于治疗不建议接受背部手术的人的慢性背痛。 2023 年 9 月，Neuralink 获得独立审查委员会的批准，开始招募针对瘫痪患者的脑植入物的首次人体试验。该研究将使用机器人透过手术将脑机介面（BCI）植入物植入大脑控制身体运动的区域。

因此，神经系统疾病盛行率的增加、研发活动的增加以及脑植入物的技术进步预计将推动未来脑植入物市场的成长。

北美脑植入市场收入及 2030 年预测（百万美元）

北美脑植入市场细分

北美脑植入市场分为治疗、应用、最终用户和国家。

根据治疗方式，北美脑植入物市场分为深部脑部刺激器、脊髓刺激器、迷走神经刺激器、侵入性和非侵入性脑机介面、癫痫反应性神经刺激器、听觉脑干植入物和眼科辅助/植入物。此外，听觉脑干植入段分为耳蜗后听力障碍和耳蜗听力障碍。 2022 年，脊髓刺激领域占最大份额。

从应用来看，北美脑植入市场分为慢性疼痛、巴金森氏症、阿兹海默症、癫痫、原发性震颤、忧郁症、肌张力失调、肌萎缩性侧索硬化症（ALS）和神经纤维瘤病2。

根据最终用户，北美脑植入市场分为医院和专科诊所/神经中心。 2022 年，医院细分市场占最大份额。

依国家/地区划分，北美脑植入市场分为美国、加拿大和墨西哥。 2022年，美国在北美脑植入市场占据主导地位。

Abbott Laboratories、Blackrock Microsystems Inc、Boston Scientific Corp、BrainGate、Fisher Wallace Laboratories Inc、Functional Neuromodulation Ltd、Medtronic Plc、Neuralink Corp、NeuroPace Inc、NeuroSky Inc、Neurospine LLC、ONWARD Medical NV、Paradromics Inc.北美脑植入市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美脑植入市场格局

  • 概述
  • 北美 PEST 分析

第 5 章：北美脑植入市场 - 主要产业动态

  • 主要市场驱动因素
    • 随着老年人口的增加，神经系统疾病的盛行率激增
    • 脊髓损伤数量不断增加
  • 主要市场限制
    • 与脑植入设备和程序相关的高成本
  • 主要市场机会
    • 公司的策略倡议
  • 未来主要趋势
    • 小型化、人工智慧和现代脑机介面等技术进步
  • 影响分析：

第 6 章：脑植入市场 - 北美市场分析

  • 概述
  • 北美脑植入市场收入，2022 - 2030

第 7 章：北美脑植入市场 - 收入和 2030 年预测 - 按治疗方法

  • 概述
  • 2022 年和 2030 年北美脑植入市场收入份额（按治疗方式）（%）
  • 深部脑部刺激
  • 脊髓刺激
  • 迷走神经刺激器
  • 侵入式和非侵入式脑机接口
  • 癫痫发作的反应性神经刺激
  • 听觉脑干植入物
  • 眼科辅助器具/植入物

第 8 章：北美脑植入市场 - 2030 年收入与预测 - 按应用

  • 概述
  • 2022 年和 2030 年北美脑植入市场收入份额，按应用划分 (%)
  • 慢性疼痛
  • 帕金森氏症
  • 阿兹海默氏症
  • 癫痫
  • 特发性震颤
  • 沮丧
  • 肌张力失调
  • 肌萎缩侧索硬化症
  • 神经纤维瘤病2

第 9 章：北美脑植入市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年北美脑植入市场收入份额（按最终用户划分）（%）
  • 医院
  • 专科诊所/神经内科中心

第 10 章：北美脑植入市场 - 地理分析

  • 北美 北美脑植入市场，依主要国家收入划分（2022 年）
      • 北美 北美脑植入市场，依国家划分
      • 我们
      • 加拿大
      • 墨西哥

第 11 章：脑植入市场-产业格局

  • 概述
  • 脑植入市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Boston Scientific Corp
  • Medtronic Plc
  • Functional Neuromodulation Ltd
  • Fisher Wallace Laboratories Inc
  • Synchron Inc
  • Blackrock Microsystems Inc
  • Renishaw Plc
  • Abbott Laboratories
  • Neurospine LLC
  • BrainGate
  • NeuroSky Inc
  • Neuralink Corp
  • NeuroPace Inc
  • ONWARD Medical NV
  • Paradromics Inc

第 13 章：附录

Product Code: BMIRE00029805

The North America brain implants market was valued at US$ 3,131.97 million in 2022 and is expected to reach US$ 7,768.72 million by 2030; it is estimated to grow at a CAGR of 12.0% from 2022 to 2030.

Surging Prevalence of Neurological Disorders with Increasing Geriatric Population Fuels North America Brain Implants Market

With age, elderly people are likely to develop neurological disorders that impact their mobility. Alzheimer's disease, epilepsy, Parkinson's disease (PD), and dystonia are among the most common neurological disorders affecting the geriatric population. According to the 2020 population statistics by the US Census Bureau, the geriatric population reached 55.8 million, i.e., 16.8% of the national population; nearly 1 in 6 people in the country were aged 65 and above in 2020. Further, as per the data published by the Fraser Institute, the share of Canada's population aged 65 or older increased from 14% in 2010 to 19% in 2022 and is expected to reach 22.5% by 2030. According to an article published by UpToDate Inc. in August 2021, the incidence rate of epilepsy rises with age and is highest among patients aged 75 and above.

Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. For instance, ~90,000 Americans are diagnosed with PD yearly. The organization also states that the incidence of PD increases with age; nearly 1 million people in the US are living with PD, and the number is expected to reach 1.2 million by 2030. According to an article titled "Alzheimer's disease: Can deep brain stimulation help alleviate symptoms" published in April 2023, ~32 million people worldwide have Alzheimer's disease. As per the Alzheimer's Disease Research Factsheet, published by BrightFocus Foundation in October 2022, ~500,000 new cases of Alzheimer's disease were diagnosed in 2022 in the US. The incidence rate of Alzheimer's increases with age. ~6.5 million Americans aged 65 and above are suffering from Alzheimer's disease, and the number is expected to reach 12.7 million by 2050. According to the World Health Organization (WHO) stats released in February 2022, approximately 50 million people suffer from epilepsy, which is one of the most common neurological diseases worldwide.

The increasing incidence of neurological diseases, coupled with the growing geriatric population, drives the demand for brain implants to treat and manage the disease. The deep brain stimulation (DBS) technique is used to treat epilepsy cases due to the low therapeutic response exhibited by the patient's body to medication during seizures and reduced success rates associated with surgeries. Researchers from the University of North Carolina at Chapel Hill claim to have generated new neurons in the brain, which can be stimulated using DBS. DBS for Alzheimer's involves utilizing an implanted device similar to a heart pacemaker and two attached wires that deliver mild electrical pulses directly to the fornix area of the brain. Electrical stimulation can activate the memory circuitry in the brain to sharpen its function. Thus, neural implants such as DBS and vagus nerve stimulation are increasingly being used to treat patients with PD and other neurological conditions.

North America Brain Implants Market Overview

The North America brain implants market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The increasing prevalence of neurological diseases such as Parkinson's disease (PD), growing awareness about neurological disorders, positive research results, and growing investments in developing various stimulators are among the main factors driving the overall market growth for brain implants in the US. According to the Parkinson's Foundation, 930,000 people in the US were suffering from PD in 2020, and the number is expected to increase to 1.2 million by 2030. Brain implants, such as deep brain stimulation (DBS), have proven to be potential treatment options for PD. DBS devices have been observed to be effective in controlling tremors associated with PD. As per the Oregon Health & Science University (OSHU) Brain Institute, in the US, ~90% of patients with essential tremors experienced moderate relief from symptoms after DBS.

According to a study titled "2022 Alzheimer's disease facts and figures," published in March 2022, ~6.5 million Americans aged 65 and above were found to have Alzheimer's disease in 2022, and the number is projected to rise to 13.8 million by 2060. Moreover, major market players focus on introducing new versions of DBS devices. In March 2023, researchers at Michigan Technological University used neuromorphic computing to improve the efficacy and energy efficiency of DBS systems used to treat PD. Similarly, researchers from the University of North Carolina at Chapel Hill discovered that they were able to generate new neurons in the brain and stimulate them using DBS. This process helped restore cognitive and noncognitive functions in a mouse model that had Alzheimer's disease.

Technological advancements and new product launches drive the growth of the US brain implants market. In January 2020, Abbott's Infinity DBS System received US Food and Drug Administration (FDA) approval for treating PD. This system targets a specific area of the brain (the inner globus pallidus), which is associated with the symptoms of PD. In September 2020, Boston Scientific announced the European launch of the WaveWriter Alpha portfolio of SCS systems. In May 2023, Abbott received approval from the US FDA for spinal cord stimulator (SCS) devices to treat chronic back pain in people who are not recommended to receive back surgery. In September 2023, Neuralink received approval from an independent review board to initiate recruitment for the first human trial of brain implants for paralysis patients. The study will involve a robot to surgically place a brain-computer interface (BCI) implant in the area of the brain that controls bodily movements.

Therefore, increasing prevalence of neurological diseases, rising research and development activities, and technological advancements in brain implants are expected to bolster the brain implants market growth in the future.

North America Brain Implants Market Revenue and Forecast to 2030 (US$ Million)

North America Brain Implants Market Segmentation

The North America brain implants market is segmented into treatment, application, end user, and country.

Based on treatment, the North America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.

In terms of application, the North America brain implants market is categorized into chronic pain, Parkinson's disease, Alzheimer's disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.

Based on end user, the North America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.

Based on country, the North America brain implants market is segmented the US, Canada, and Mexico. The US dominated the North America brain implants market in 2022.

Abbott Laboratories, Blackrock Microsystems Inc, Boston Scientific Corp, BrainGate, Fisher Wallace Laboratories Inc, Functional Neuromodulation Ltd, Medtronic Plc, Neuralink Corp, NeuroPace Inc, NeuroSky Inc, Neurospine LLC, ONWARD Medical NV, Paradromics Inc, Renishaw Plc, and Synchron Inc are some of the leading companies operating in the North America brain implants market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Brain Implants Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Brain Implants Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
    • 5.1.2 Rising Number of Spinal Cord Injuries
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost Associated with Brain Implant Devices and Procedures
  • 5.3 Key Market Opportunities
    • 5.3.1 Strategic Initiatives by Companies
  • 5.4 Key Future Trends
    • 5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
  • 5.5 Impact Analysis:

6. Brain Implants Market - North America Market Analysis

  • 6.1 Overview
  • 6.2 North America Brain Implants Market Revenue (US$ Mn), 2022 - 2030

7. North America Brain Implants Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 North America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Deep Brain Stimulation
    • 7.3.1 Overview
    • 7.3.2 Deep Brain Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Spinal Cord Stimulation
    • 7.4.1 Overview
    • 7.4.2 Spinal Cord Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Vagus Nerve Stimulator
    • 7.5.1 Overview
    • 7.5.2 Vagus Nerve Stimulator: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Invasive and Non-Invasive Brain-Computer Interfaces
    • 7.6.1 Overview
    • 7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Responsive Neurostimulation for Seizures
    • 7.7.1 Overview
    • 7.7.2 Responsive Neurostimulation for Seizures: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Auditory Brainstem Implant
    • 7.8.1 Overview
    • 7.8.2 Auditory Brainstem Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.8.2.1 Retrocochlear Hearing Impairment
        • 7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
      • 7.8.2.2 Cochlear Hearing Impairment
        • 7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Ophthalmic Aids/Implant
    • 7.9.1 Overview
    • 7.9.2 Ophthalmic Aids/Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Brain Implants Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Chronic Pain
    • 8.3.1 Overview
    • 8.3.2 Chronic Pain: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Parkinson's disease
    • 8.4.1 Overview
    • 8.4.2 Parkinson's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Alzheimer's disease
    • 8.5.1 Overview
    • 8.5.2 Alzheimer's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Epilepsy
    • 8.6.1 Overview
    • 8.6.2 Epilepsy: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Essential Tremor
    • 8.7.1 Overview
    • 8.7.2 Essential Tremor: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Depression
    • 8.8.1 Overview
    • 8.8.2 Depression: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Dystonia
    • 8.9.1 Overview
    • 8.9.2 Dystonia: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Amyotrophic Lateral Sclerosis
    • 8.10.1 Overview
    • 8.10.2 Amyotrophic Lateral Sclerosis (ALS): North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Neurofibromatosis 2
    • 8.11.1 Overview
    • 8.11.2 Neurofibromatosis 2: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Brain Implants Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 North America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Specialized Clinics / Neurological Centers
    • 9.4.1 Overview
    • 9.4.2 Specialized Clinics / Neurological Centers: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Brain Implants Market - Geographical Analysis

  • 10.1 North America North America Brain Implants Market, by Key Country-Revenue (2022)
      • 10.1.1.1 North America North America Brain Implants Market, by Country
      • 10.1.1.2 US
        • 10.1.1.2.1 US: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 US: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 US: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.1.2.3 US: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4 US: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 Canada
        • 10.1.1.3.1 Canada: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Canada: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 Canada: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Canada: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Canada: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.4 Mexico
        • 10.1.1.4.1 Mexico : North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Mexico: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.4.2.1 Mexico: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Mexico: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Mexico: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)

11. Brain Implants Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Brain Implants Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Boston Scientific Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Functional Neuromodulation Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 SWOT Analysis
    • 12.3.5 Key Developments
  • 12.4 Fisher Wallace Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Synchron Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 SWOT Analysis
    • 12.5.5 Key Developments
  • 12.6 Blackrock Microsystems Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 SWOT Analysis
    • 12.6.5 Key Developments
  • 12.7 Renishaw Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Abbott Laboratories
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Neurospine LLC
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 SWOT Analysis
    • 12.9.5 Key Developments
  • 12.10 BrainGate
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 SWOT Analysis
    • 12.10.5 Key Developments
  • 12.11 NeuroSky Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 SWOT Analysis
    • 12.11.5 Key Developments
  • 12.12 Neuralink Corp
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 SWOT Analysis
    • 12.12.5 Key Developments
  • 12.13 NeuroPace Inc
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 ONWARD Medical NV
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Paradromics Inc
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 SWOT Analysis
    • 12.15.5 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Brain Implants Market Segmentation
  • Table 2. US: North America Brain Implants Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Brain Implants Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America Brain Implants Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Brain Implants Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America Brain Implants Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America Brain Implants Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico : North America Brain Implants Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico : North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico : North America Brain Implants Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico : North America Brain Implants Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Recent Organic Growth Strategies in Brain Implants Market
  • Table 15. Recent Inorganic Growth Strategies in the Brain Implants Market
  • Table 16. Glossary of Terms, North America Brain Implants Market

List Of Figures

  • Figure 1. North America Brain Implants Market Segmentation, By Country
  • Figure 2. North America PEST Analysis
  • Figure 3. North America Brain Implants Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Brain Implants Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 7. Deep Brain Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Spinal Cord Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Vagus Nerve Stimulator: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Invasive and Non-Invasive Brain-Computer Interfaces: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Responsive Neurostimulation for Seizures: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Auditory Brainstem Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Retrocochlear Hearing Impairment: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cochlear Hearing Impairment: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ophthalmic Aids/Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Chronic Pain: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Parkinson's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Alzheimer's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Epilepsy: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Essential Tremor: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Depression: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Dystonia: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Amyotrophic Lateral Sclerosis (ALS): North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Neurofibromatosis 2: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. North America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 27. Hospitals: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Specialized Clinics / Neurological Centers: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America: Brain Implants Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. North America Brain Implants Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. US: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Canada: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Mexico : North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Growth Strategies in Brain Implants Market